Atai Life Sciences Pre-Paid Expenses 2020-2024 | ATAI

Atai Life Sciences pre-paid expenses from 2020 to 2024. Pre-paid expenses can be defined as a current asset created by prepayment of costs and expenses for which the benefits will occur at a future date.
Atai Life Sciences Annual Pre-Paid Expenses
(Millions of US $)
2023 $6
2022 $14
2021 $12
2020 $2
2019 $1
Atai Life Sciences Quarterly Pre-Paid Expenses
(Millions of US $)
2024-09-30 $7
2024-06-30 $5
2024-03-31 $6
2023-12-31 $6
2023-09-30 $7
2023-06-30 $6
2023-03-31 $9
2022-12-31 $14
2022-09-30 $13
2022-06-30 $11
2022-03-31 $13
2021-12-31 $12
2021-09-30 $12
2021-06-30 $4
2021-03-31 $4
2020-12-31 $2
2020-09-30
2020-06-30
2020-03-31
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.200B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.704B 11.92
Quest Diagnostics (DGX) United States $16.912B 17.14
DaVita (DVA) United States $12.098B 15.65
Encompass Health (EHC) United States $9.453B 22.29
Chemed (CHE) United States $7.853B 24.14
Elanco Animal Health (ELAN) United States $5.843B 13.91
RadNet (RDNT) United States $5.284B 117.02
Option Care Health (OPCH) United States $3.848B 18.23
Amedisys (AMED) United States $2.744B 19.53
LifeStance Health (LFST) United States $2.698B 0.00
Addus HomeCare (ADUS) United States $2.350B 27.57
Astrana Health (ASTH) United States $1.974B 26.99
U.S Physical Therapy (USPH) United States $1.380B 36.27
Pennant (PNTG) United States $0.938B 37.92
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00